The five-year, $5 million Atlas of Retinal Imaging in Alzheimer’s Study (ARIAS) is sponsored by BayCare Health System’s Morton Plant Hospital and St. Anthony’s Hospital and funded largely by Morton Plant Mease Health Care Foundation and St. Anthony’s Hospital Foundation in Pinellas County, Florida.
The three-day event highlights innovation in glaucoma therapies to ensure patients have access to the latest and most effective diagnostic tools and treatment options.
Researchers combined eye gaze research with brain scans to discover that in a common subtype of autism, in which ASD toddlers prefer images of geometric shapes over those of children playing, brain areas responsible for vision and attention are not controlled by social brain networks, and so social stimuli are ignored.
Ophthalmology industry innovators Vicente Anido, Jr., PhD and Thomas A. Mitro of Aerie Pharmaceuticals, Inc. will be honored at the Glaucoma 360 Annual Gala on February 6, 2020 in San Francisco.
With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.
Two of the world’s largest ophthalmic organizations have finalized their joint venture Ophthovation™ to develop business conferences that accelerate innovation in ophthalmology called the Ophthovation™ Conference.
A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital analyzed data regarding eye exposures associated with household cleaning products from 2000 through 2016 and found a decrease in the number of exposures during this period. However, the number of these exposures among young children remains high.
Gender differences in the ability to recognize female celebrities linked to the level of a country’s gender equality
An Ohio State University eye specialist explains snow blindness and how to avoid it.
Mass. Eye and Ear scientists report the identification of a new pathway linked to cell division in the ear. With this pathway, they were able to reprogram the inner ear’s cells to proliferate and regenerate hair cell-like cells in adult mouse models.
Working with the Canadian Space Agency and NASA, two Quebec-based researchers are keeping an eye on astronauts’ ocular health.
People with visual impairments use social media like everyone else, often with the help of screen reader software.
In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye. The findings, they conclude, bring scientists a step closer to developing new drugs for a central vision-destroying complication of diabetes that affects an estimated 750,000 Americans.
By the second trimester, long before a baby's eyes can see images, they can detect light.
A new study conducted by researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital investigated nonpowder firearm injuries treated in U.S. emergency departments (EDs) among children younger than 18 years from 1990 through 2016. It found an overall decrease in the rate of nonpowder firearm injuries during the study period, but an increasing rate of eye injuries related to nonpowder firearms.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects. Jinglin Huang, a graduate student in medical engineering at Caltech, suggests inefficient fluid mixing of the injected medicine and the gel within the eye may be to blame.
Neuroscientists have decoded how visual cues reorganize the activity of compass neurons in fruit flies to maintain an accurate sense of direction. Tracking individual neurons as flies navigate a virtual reality environment, they shed light on how organisms build a spatial map of their world.
How do we perceive our environment? What is the influence of sensory stimuli on the peripheral nervous system and what on the brain?
Shravani Mikkilineni, M.D., MBA, resident physician in Henry Ford Health System’s Department of Ophthalmology, was recognized among the top five honorees in the third-annual Ophthalmology Times® Research Scholar Honoree Program, earning first place for her presented research, “T2 Magnetic Resonance Assay for Detection of Ocular Candidiasis.”
Researchers at the National Eye Institute used artificial intelligence to evaluate stem cell-derived “patches” of retinal pigment epithelium tissue for implanting into the eyes of patients with age-related macular degeneration, a leading cause of blindness.
The Association for Research in Vision and Ophthalmology (ARVO) and the Eye Bank Association of America (EBAA) today announced a new grant program that will provide financial support to researchers seeking to use human eye tissue in their work.
The Virginia Murray Sowell Center for Research and Education in Sensory Disabilities at Texas Tech University will train scholars as teachers of students with visual impairments, or orientation and mobility specialists, and allow them to complete a master’s degree in special education.
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor (TNFi) inhibitors first (Abstract# 2911).
Awards were presented to Philadelphia Mayor Jim Kenney; Thomas Jefferson University President and Jefferson Health CEO, Stephen Klasko, MD, MBA; Benefactor Steven H. Korman and Wills Eye Alumnus and Surgeon-Scientist, Jay Duker, MD
Study is the first to identify specific cellular toxicity and show improvement after stopping supplement use
The American Academy of Ophthalmology is urging people to buy decorative contact lenses only from retailers who require a prescription and sell FDA-approved products.
The 2019-2020 Senior Capstone in Engineering (SCOPE) program officially got underway in September. Fourteen corporate partners have signed on to sponsor SCOPE teams made up of Olin seniors. It is SCOPE’s fifteenth year. The sponsors include: Amazon Robotics, Arthur G. Russell, Boeing, Boston Scientific, CUAHSI, Ford Motor, GE Healthcare, Microsoft, Pfizer, Santos Family Foundation, Sonos, Toyota, Valve Corp and Watts Water Technologies.
Georgetown neuroscientists say they have identified how people can have a “crash in visual processing” — a bottleneck of feedforward and feedback signals that can cause us not to be consciously aware of stimuli that our brain recognized.
Wills Eye Hospital today announced its Ophthalmologist-in-Chief, Julia A. Haller, MD, has been elected to the National Academy of Medicine (NAM), considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service.
Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.
Registration is now open for the 11th The Eye and The Chip research congress, which will take place Nov. 10-12, 2019 at The Henry Hotel in Dearborn, Michigan. This year’s research congress will focus on the relationship between neurobiology and nanoelectronics with respect to artificial vision. The ultimate goal of the research congress is to advance progress toward artificial vision for many people who suffer from blindness.
Krzysztof Palczewski, the Irving H. Leopold Chair in Ophthalmology and a professor of physiology & biophysics at the University of California, Irvine, has been elected to the National Academy of Medicine, one of the highest distinctions accorded to professionals in the medical sciences, healthcare and public health.
Rutgers University has launched the nation’s first peer support helpline for the legally blind and their families.
Researchers from Massachusetts Eye and Ear, Harvard Medical School and a team of EPFL researchers have developed a conformable electrode implant that will allow people with a dysfunctional inner ear to hear again. This new technology would improve existing auditory brainstem implants, which have a number of shortcomings.
Researchers at the IU School of Optometry have used adaptive optics technology to create the first undistorted microscopic images of the eye's trabecular meshwork, which could help improve treatment for glaucoma.
New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time.
The American Academy of Ophthalmology is honoring ophthalmologists who have improved eye care for millions worldwide through their commitment to their patients and their profession.
A drug widely prescribed for a bladder condition for decades now appears to be toxic to the retina, the light-sensing tissue at the back of the eye that allows us to see.
Researchers in Australia used a driving simulator to test patients’ vision before and after cataract surgery.
Combining two different treatment methods to slow the progression of myopia may deliver better results in slowing the progression of myopia.
Gene therapy is showing promise for one of the most common causes of blindness.
Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid. They are also the first to demonstrate that patients with dry eye disease experienced reduced signs and symptoms of the condition in response to a new eye drop treatment -- made from pooled human antibodies -- that targets ACPAs.
From today’s perspective, the idea of computer systems that track our tiniesteye movements may seem like a far-off futurist’s dream.
More than 25,000 are expected to attend the American Academy of Ophthalmology’s 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco.
Staggering new statistics released by the World Health Organization (WHO) in its first World Report on Vision estimate more than 1 billion people are visually impaired because they don’t get the care they need—a finding that brings renewed urgency for sustainable global outreach efforts. The statistics underscore the need for programs like the donor-funded John A. Moran Eye Center Global Outreach Division at the University of Utah, which works to create sustainable eye care systems in developing nations and to reach underserved populations in Utah.
Research to Prevent Blindness (RPB) is pleased to announce that RPB Stein Innovation Awardee Gregg Semenza, MD, PhD, at Johns Hopkins University School of Medicine, has been named a winner of the 2019 Nobel Prize in Medicine.
Massachusetts Eye and Ear raised more than 1.3 million at its 10th Annual Sense-ation! Gala on October 7, 2019, at the Westin Boston Waterfront. Guests were treated to a specially-arranged performance from cast members from Disney’s The Lion King, presented by Broadway In Boston.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right